South Korean company Dong-A ST wins FDA approval for Stelara biosimilar – Pharmaceutical Technology
Stelara is indicated for use in patients with active psoriatic arthritis as well as moderate to severe Crohn’s disease, plaque psoriasis, and active ulcerative colitis.